tiprankstipranks
Meihua International Medical Technologies Co Ltd (MHUAF)
OTHER OTC:MHUAF
US Market
Want to see MHUAF full AI Analyst Report?

Meihua International Medical Technologies Co Ltd (MHUAF) Ratios

47 Followers

Meihua International Medical Technologies Co Ltd Ratios

MHUAF's free cash flow for Q4 2025 was $0.27. For the 2025 fiscal year, MHUAF's free cash flow was decreased by $ and operating cash flow was $0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
8.42 8.42 5.26 5.27 5.60
Quick Ratio
8.32 8.32 5.21 5.21 5.55
Cash Ratio
0.83 0.83 0.59 0.68 1.11
Solvency Ratio
0.40 0.40 0.42 0.48 0.27
Operating Cash Flow Ratio
0.03 0.03 0.54 0.09 -0.38
Short-Term Operating Cash Flow Coverage
0.06 0.06 1.84 0.31 -1.50
Net Current Asset Value
$ 135.33M$ 135.33M$ 116.17M$ 107.16M$ 110.42M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.04 0.04 0.04 0.04
Debt-to-Equity Ratio
0.05 0.05 0.05 0.05 0.05
Debt-to-Capital Ratio
0.05 0.05 0.05 0.05 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 <0.01
Financial Leverage Ratio
1.10 1.10 1.17 1.17 1.18
Debt Service Coverage Ratio
0.66 0.67 1.37 1.63 1.10
Interest Coverage Ratio
22.74 34.30 9.50 58.52 55.49
Debt to Market Cap
1.52 11.66 0.84 0.21 0.04
Interest Debt Per Share
13.44 24.54 34.53 31.67 29.94
Net Debt to EBITDA
-0.70 -0.70 -0.51 -0.61 -1.71
Profitability Margins
Gross Profit Margin
30.88%30.74%34.36%34.08%36.86%
EBIT Margin
13.41%13.41%15.62%15.76%10.73%
EBITDA Margin
14.30%14.30%16.20%16.24%11.27%
Operating Profit Margin
13.41%13.41%14.77%15.11%10.45%
Pretax Profit Margin
15.22%15.22%14.06%15.50%10.54%
Net Profit Margin
10.98%10.98%11.19%11.97%6.04%
Continuous Operations Profit Margin
10.98%10.98%11.18%11.94%5.98%
Net Income Per EBT
72.10%72.10%79.58%77.25%57.32%
EBT Per EBIT
113.54%113.54%95.21%102.55%100.83%
Return on Assets (ROA)
3.27%3.27%5.82%6.76%3.82%
Return on Equity (ROE)
3.83%3.59%6.82%7.94%4.52%
Return on Capital Employed (ROCE)
4.38%4.38%9.00%9.99%7.75%
Return on Invested Capital (ROIC)
3.02%3.02%6.82%7.33%4.21%
Return on Tangible Assets
3.28%3.28%5.84%6.92%3.83%
Earnings Yield
115.38%879.76%114.80%32.81%3.22%
Efficiency Ratios
Receivables Turnover
0.52 0.52 0.84 0.98 1.14
Payables Turnover
5.07 5.08 4.11 4.05 4.05
Inventory Turnover
25.06 25.11 45.12 39.58 58.15
Fixed Asset Turnover
8.03 8.03 12.29 10.99 11.80
Asset Turnover
0.30 0.30 0.52 0.56 0.63
Working Capital Turnover Ratio
0.48 0.49 0.87 0.89 1.15
Cash Conversion Cycle
647.69 647.81 352.42 292.95 237.74
Days of Sales Outstanding
705.08 705.08 433.13 373.95 321.51
Days of Inventory Outstanding
14.56 14.54 8.09 9.22 6.28
Days of Payables Outstanding
71.95 71.81 88.80 90.23 90.04
Operating Cycle
719.65 719.62 441.22 383.17 327.78
Cash Flow Ratios
Operating Cash Flow Per Share
0.82 1.52 53.47 9.51 -39.14
Free Cash Flow Per Share
0.80 1.47 52.99 -10.07 -50.67
CapEx Per Share
0.02 0.04 0.49 19.58 11.53
Free Cash Flow to Operating Cash Flow
0.97 0.97 0.99 -1.06 1.29
Dividend Paid and CapEx Coverage Ratio
36.46 36.45 109.60 0.49 -3.40
Capital Expenditure Coverage Ratio
36.46 36.45 109.60 0.49 -3.40
Operating Cash Flow Coverage Ratio
0.06 0.06 1.84 0.31 -1.34
Operating Cash Flow to Sales Ratio
<0.01 <0.01 0.15 0.02 -0.09
Free Cash Flow Yield
9.40%71.90%153.54%-6.80%-6.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.87 0.11 0.87 3.05 31.05
Price-to-Sales (P/S) Ratio
0.10 0.01 0.10 0.36 1.88
Price-to-Book (P/B) Ratio
0.03 <0.01 0.06 0.24 1.40
Price-to-Free Cash Flow (P/FCF) Ratio
10.64 1.39 0.65 -14.70 -16.34
Price-to-Operating Cash Flow Ratio
10.31 1.35 0.65 15.57 -21.15
Price-to-Earnings Growth (PEG) Ratio
-0.01 >-0.01 -0.05 0.04 -0.45
Price-to-Fair Value
0.03 <0.01 0.06 0.24 1.40
Enterprise Value Multiple
-0.03 -0.61 0.09 1.64 14.93
Enterprise Value
-269.07K -5.40M 1.43M 25.84M 173.92M
EV to EBITDA
-0.03 -0.61 0.09 1.64 14.93
EV to Sales
>-0.01 -0.09 0.01 0.27 1.68
EV to Free Cash Flow
-0.49 -9.73 0.10 -10.72 -14.66
EV to Operating Cash Flow
-0.47 -9.47 0.10 11.35 -18.98
Tangible Book Value Per Share
270.97 501.24 579.18 597.00 590.24
Shareholders’ Equity Per Share
271.61 502.43 580.80 611.24 589.99
Tax and Other Ratios
Effective Tax Rate
0.28 0.28 0.20 0.23 0.43
Revenue Per Share
88.83 164.33 354.05 405.59 441.44
Net Income Per Share
9.75 18.04 39.62 48.56 26.67
Tax Burden
0.72 0.72 0.80 0.77 0.57
Interest Burden
1.14 1.14 0.90 0.98 0.98
Research & Development to Revenue
0.04 0.04 0.04 0.03 0.03
SG&A to Revenue
0.13 0.13 0.14 0.08 0.12
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.08 0.08 1.35 0.20 -1.48
Currency in USD